About t2cure
t2cure GmbH is a biopharmaceutical company engaged in the field of stem cell-based regenerative medicine. It develops and markets autologous bone marrow-derived progenitor cells as regenerative therapeutics for cardiovascular disease including ischemic heart disease (acute myocardial infarction and chronic ischemic heart disease), non-ischemic heart failure and peripheral arterial occlusive disease. The most advanced project (t2c001-AMI) has successfully passed Phase II of clinical development.
Facts about t2cure
Facts about t2cure
- Founding: 2008
- Focus : Service
- Industry : Biotechnology
